|
시장보고서
상품코드
2050608
엑소좀 진단 및 치료 시장 : 유형별, 제품 유형별, 서비스별, 유래별, 용도별, 최종사용자별, 지역별Exosomes Diagnostic and Therapeutic Market, By Type, By Product & Service, By Source, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
엑소좀 진단·치료 시장은 2026년에 1억 1,030만 달러로 추계되고 있으며, 2033년까지 3억 7,070만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 18.9%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 1억 1,030만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 18.90% | 2033년 시장 규모 예측 : | 3억 7,070만 달러 |
세계 엑소좀 진단 및 치료 시장은 최근 수년간 괄목할 만한 성장을 거듭하고 있습니다. 엑소좀은 단백질, 지질, 핵산 등 생체 분자의 운반체 역할을 하는 나노 크기의 세포외 소포입니다. 이들은 세포 간 소통과 면역 반응에서 중요한 역할을 합니다. 암, 신경질환, 심혈관질환 등 다양한 질환의 진단 및 치료에 엑소좀의 적용이 확대되면서 이 시장의 성장을 촉진하고 있습니다. 연구자 및 헬스케어 업계 관계자들은 저침습적 액체생검, 약물전달 솔루션, 재생의료 개발을 위해 엑소좀의 잠재력을 점점 더 많이 활용하고 있습니다. 분리 및 특성화 기술의 발전으로 엑소좀의 연구 범위와 임상 적용이 더욱 확대되고 있습니다.
시장 역학
엑소좀 진단 및 치료 시장을 촉진하는 주요 시장 촉진요인으로는 비침습적 진단법에 대한 수요 증가, 대상 질환의 유병률 증가, 기존 약물 대비 엑소좀 기반 치료제의 장점, 기술 발전 등을 들 수 있습니다. 그러나 분리 기술 및 특성화 툴에 따른 높은 비용과 표준화 부족으로 인해 시장 성장이 제한되고 있습니다. 한편, 접근성 향상과 지속적인 개선으로 새로운 기회가 생겨나고 있습니다. 노화 방지 치료, 불임 치료, 감염 대책의 새로운 응용 분야도 유망한 분야로 꼽히고 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개변수(회사 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략)를 기반으로 세계의 엑소좀 진단 및 치료 시장의 주요 업체를 분석합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 세계의 엑소좀 진단 및 치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 엑소좀 진단 및 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 엑소좀 진단·치료 시장 : 유형별, 2026-2033년
제5장 세계의 엑소좀 진단·치료 시장 : 제품·서비스별, 2026-2033년
제6장 세계의 엑소좀 진단·치료 시장 : 소스별, 2026-2033년
제7장 세계의 엑소좀 진단·치료 시장 : 용도별, 2026-2033년
제8장 세계의 엑소좀 진단·치료 시장 : 최종사용자별, 2026-2033년
제9장 세계의 엑소좀 진단·치료 시장 : 지역별, 2026-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
KSA 26.06.10Exosomes Diagnostic and Therapeutic Market is estimated to be valued at USD 110.3 Mn in 2026 and is expected to reach USD 370.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 18.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 110.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 18.90% | 2033 Value Projection: | USD 370.7 Mn |
The global exosomes diagnostic and therapeutic market has been witnessing significant growth in the recent years. Exosomes are nano-sized extracellular vesicles that act as carriers of biomolecules like proteins, lipids, and nucleic acids. They play an important role in cell-to-cell communication and immune response. The growing application of exosomes in diagnosis and treatment of various diseases like cancer, neurological disorders, and cardiovascular conditions is driving the growth of this market. Researchers and healthcare industry players are increasingly leveraging the potential of exosomes for developing minimally invasive liquid biopsies, drug delivery solutions, and regenerative therapies. Advancements in isolation and characterization techniques are further expanding the scope of research as well as clinical use of exosomes.
Market Dynamics
The key drivers propelling the exosomes diagnostic and therapeutic market include growing demand for non-invasive diagnostic methods, increasing prevalence of target diseases, advantages of exosome-based therapies over conventional drugs, and technological advancements. However, high costs associated with isolation techniques and characterization tools, as well as lack of standardization are limiting the market growth. On the positive side, improved access and ongoing refinements are creating new opportunities. Emerging applications in anti-aging therapeutics, fertility management, and infection control also hold promise.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global exosomes diagnostic and therapeutic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, NanoSomix, NX Pharmagen, , Malvern Instruments, Capricor Therapeutic, Exosome Diagnostics, Exiqon A/S, System Biosciences, Exosome Sciences, Aegle Therapeutic, AMS Biotechnology, Miltenyi Biotec, Codiak BioSciences Inc., Lonza Group (HansaBioMed Life Sciences Ltd.), AcouSort AB, Aethlon Medical, Inc., AGC Biologics, Anjarium Biosciences AG, Aruna Bio, Brexogen, Capricor Therapeutics, Cells for Cells, Ciloa, ConvEyXO
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global exosomes diagnostic and therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exosomes diagnostic and therapeutic market.
Market Segmentation
- By Type Insights (Revenue, USD Mn, 2021 - 2033)
- Exosome Diagnostics
- Exosome Therapeutics
- By Product & Service Insights (Revenue, USD Mn, 2021 - 2033)
- Instruments & Services
- Kits & Reagents
- By Source Insights (Revenue, USD Mn, 2021 - 2033)
- Stem Cells
- Blood & Blood Plasma
- Urine
- Other Sources
- By Application Insights (Revenue, USD Mn, 2021 - 2033)
- Cancer
- Dermatological Diseases
- Musculoskeletal Disorders
- Cardiovascular Diseases
- Others
- By End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals & Diagnostic Centers
- Clinics and Physician Settings
- Academic and Research Institutions
- Contract Research Organizations
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- NanoSomix
- NX Pharmagen
- Malvern Instruments
- Capricor Therapeutic
- Exosome Diagnostics
- Exiqon A/S
- System Biosciences
- Exosome Sciences
- Aegle Therapeutic
- AMS Biotechnology
- Miltenyi Biotec
- Codiak BioSciences Inc.
- Lonza Group (HansaBioMed Life Sciences Ltd.)
- AcouSort AB
- Aethlon Medical, Inc.
- AGC Biologics
- Anjarium Biosciences AG
- Aruna Bio
- Brexogen
- Capricor Therapeutics
- Cells for Cells
- Ciloa
- ConvEyXO
Table of Contents
1. RESEARCH OBJECTIVES AND ASSUMPTIONS
- Research Objectives
- Assumptions
- Abbreviations
2. MARKET PURVIEW
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Exosomes Diagnostic and Therapeutic Market, By Type
- Global Exosomes Diagnostic and Therapeutic Market, By Product & Service
- Global Exosomes Diagnostic and Therapeutic Market, By Source
- Global Exosomes Diagnostic and Therapeutic Market, By Application
- Global Exosomes Diagnostic and Therapeutic Market, By End User
- Global Exosomes Diagnostic and Therapeutic Market, By Region
3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Exosomes Diagnostic and Therapeutic Market, By Type, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Exosome Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Exosome Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
5. Global Exosomes Diagnostic and Therapeutic Market, By Product & Service, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Instruments & Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Kits & Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
6. Global Exosomes Diagnostic and Therapeutic Market, By Source, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Blood & Blood Plasma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Other Sources
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
7. Global Exosomes Diagnostic and Therapeutic Market, By Application, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Dermatological Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Musculoskeletal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
8. Global Exosomes Diagnostic and Therapeutic Market, By End User, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Hospitals & Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Clinics and Physician Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
9. Global Exosomes Diagnostic and Therapeutic Market, By Region, 2026 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2026 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. COMPETITIVE LANDSCAPE
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NanoSomix
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NX Pharmagen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Malvern Instruments
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Capricor Therapeutic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Exosome Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Exiqon A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- System Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Exosome Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aegle Therapeutic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AMS Biotechnology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Miltenyi Biotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Codiak BioSciences Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group (HansaBioMed Life Sciences Ltd.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AcouSort AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aethlon Medical, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AGC Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Anjarium Biosciences AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aruna Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Brexogen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Capricor Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cells for Cells
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ciloa
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ConvEyXO
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
